Trial intelligence / Profile preview

Evoked Resistance Training and Testosterone in Spinal Cord Injury

NCT01652040Phase 3Completed

Sponsor
VA Office of Research & Development
Start
Jul 2012
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of testosterone in obesity, type 2 diabetes mellitus (T2DM), dyslipidemia, sponsored by VA Office of Research & Development. Started Jul 2012; status: completed.

02

Drugs

testosterone
03

Conditions

obesitytype 2 diabetes mellitus (T2DM)dyslipidemia

Beyond the preview

Go deeper on NCT01652040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01652040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call